[
  {
    "title": "博雅生物股东高特佳集团质押1600万股 用于融资",
    "href": "http://stock.jrj.com.cn/2022/12/21211137229586.shtml",
    "datetime": "2022-12-21 21:11:58",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：高特佳集团质押1600万股",
    "href": "http://stock.jrj.com.cn/2022/12/21162437228454.shtml",
    "datetime": "2022-12-21 16:24:42",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：股东高特佳集团及相关方收到江西证监局警示函",
    "href": "http://stock.jrj.com.cn/2022/12/11164637203912.shtml",
    "datetime": "2022-12-11 16:46:48",
    "code": "300294"
  },
  {
    "title": "博雅生物2022年前三季度净利4.18亿同比增长29.31% 理财产品收益增加",
    "href": "http://stock.jrj.com.cn/2022/10/24221137079801.shtml",
    "datetime": "2022-10-24 22:11:42",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)三季度净利1.39亿元 同比增长10.89%",
    "href": "http://stock.jrj.com.cn/2022/10/24172537078431.shtml",
    "datetime": "2022-10-24 17:25:59",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：子公司获得阿卡波糖片《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2022/09/30155637034016.shtml",
    "datetime": "2022-09-30 15:56:58",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：袁媛8月22日大宗交易减持1.77%股份",
    "href": "http://stock.jrj.com.cn/2022/08/23185036927367.shtml",
    "datetime": "2022-08-23 18:50:16",
    "code": "300294"
  },
  {
    "title": "华润医药(03320.HK)：博雅生物半年度净利2.79亿元 同比增长41.03%",
    "href": "http://stock.jrj.com.cn/2022/08/22081336919893.shtml",
    "datetime": "2022-08-22 08:13:21",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：获得“人凝血因子Ⅷ”药品注册证书",
    "href": "http://stock.jrj.com.cn/2022/08/19205836917972.shtml",
    "datetime": "2022-08-19 20:58:57",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)半年度净利润2.79亿元 同比增长41.03%",
    "href": "http://stock.jrj.com.cn/2022/08/19183836917292.shtml",
    "datetime": "2022-08-19 18:38:15",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：副董事长廖昕晰方面拟减持不超0.65%股份",
    "href": "http://stock.jrj.com.cn/2022/08/02182736863622.shtml",
    "datetime": "2022-08-02 18:27:19",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：与抚州高新区管委会签订入园合同",
    "href": "http://stock.jrj.com.cn/2022/07/01175336775899.shtml",
    "datetime": "2022-07-01 17:53:52",
    "code": "300294"
  },
  {
    "title": "140家公司获机构调研 博雅生物最受关注",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/26071636679526.shtml",
    "datetime": "2022-05-26 07:16:51",
    "code": "300294"
  },
  {
    "title": "148家公司获机构调研 博雅生物最受关注",
    "href": "http://stock.jrj.com.cn/hotstock/2022/05/24075236672489.shtml",
    "datetime": "2022-05-24 07:52:51",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：就单采血浆站投资建设及经营管理提升等与高特佳集团签署战略合作框架协议",
    "href": "http://stock.jrj.com.cn/2022/05/19182836663045.shtml",
    "datetime": "2022-05-19 18:28:04",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)2021年度权益分派10派1.5元 股权登记日为5月12日",
    "href": "http://stock.jrj.com.cn/2022/05/06204436583068.shtml",
    "datetime": "2022-05-06 20:44:39",
    "code": "300294"
  },
  {
    "title": "华润医药(03320.HK)：博雅生物一季度净利1.04亿元 同比增长2.80%",
    "href": "http://stock.jrj.com.cn/2022/04/25074936455934.shtml",
    "datetime": "2022-04-25 07:49:47",
    "code": "300294"
  },
  {
    "title": "博雅生物2022年第一季度净利1.04亿同比增长2.8% 政府补助增加",
    "href": "http://stock.jrj.com.cn/2022/04/23183036437474.shtml",
    "datetime": "2022-04-23 18:30:42",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：与华润医商贸易签署合作框架协议 涉及国际市场开发业务",
    "href": "http://stock.jrj.com.cn/2022/04/20171736410677.shtml",
    "datetime": "2022-04-20 17:17:22",
    "code": "300294"
  },
  {
    "title": "A股异动 | 博雅生物(300294.SZ)跌超5% Q4净利润同比减42%",
    "href": "http://stock.jrj.com.cn/2022/03/23110534864515.shtml",
    "datetime": "2022-03-23 11:05:26",
    "code": "300294"
  },
  {
    "title": "博雅生物2021年净利3.45亿同比增长32.48% 副董事长廖昕晰薪酬320万",
    "href": "http://stock.jrj.com.cn/2022/03/22225134862690.shtml",
    "datetime": "2022-03-22 22:51:48",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：拟变更募投项目 9.96亿元全部投入到血液制品智能工厂(一期)建设项目",
    "href": "http://stock.jrj.com.cn/2022/03/22215634862526.shtml",
    "datetime": "2022-03-22 21:56:49",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)2021年度净利润升32.48%至3.45亿元 拟10派1.5元",
    "href": "http://stock.jrj.com.cn/2022/03/22204134862263.shtml",
    "datetime": "2022-03-22 20:41:46",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：减持期届满 股东廖昕晰、嘉颐投资、大正初元未减持股份",
    "href": "http://stock.jrj.com.cn/2022/02/28174934497452.shtml",
    "datetime": "2022-02-28 17:49:18",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：拟变更公司名称为“华润博雅生物制药集团股份有限公司”",
    "href": "http://stock.jrj.com.cn/2022/01/12180134150647.shtml",
    "datetime": "2022-01-12 18:01:29",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：静注人免疫球蛋白(10%)获批临床",
    "href": "http://stock.jrj.com.cn/2021/12/29160834081254.shtml",
    "datetime": "2021-12-29 16:08:17",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：选举陶然为第七届董事会董事长",
    "href": "http://stock.jrj.com.cn/2021/12/27210834072507.shtml",
    "datetime": "2021-12-27 21:08:14",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：获批设置单采血浆站",
    "href": "http://stock.jrj.com.cn/2021/12/10185133995587.shtml",
    "datetime": "2021-12-10 18:51:34",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：计提相关资产减值准备合计7503.44万元",
    "href": "http://stock.jrj.com.cn/2021/12/10184933995582.shtml",
    "datetime": "2021-12-10 18:49:47",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：廖昕晰方面减持期过半 未减持公司股份",
    "href": "http://stock.jrj.com.cn/2021/12/01180933950788.shtml",
    "datetime": "2021-12-01 18:09:53",
    "code": "300294"
  },
  {
    "title": "华润医药入主博雅生物落地 累计耗资近48亿取得40%股权",
    "href": "http://stock.jrj.com.cn/2021/11/23170033909862.shtml",
    "datetime": "2021-11-23 17:00:36",
    "code": "300294"
  },
  {
    "title": "恩捷股份拟定增募资不超128亿；亚星客车董事长、董秘辞职；中国华润成博雅生物实控人",
    "href": "http://stock.jrj.com.cn/2021/11/23080933907682.shtml",
    "datetime": "2021-11-23 08:09:40",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：华润医药控股成为公司控股股东",
    "href": "http://stock.jrj.com.cn/2021/11/22213033905620.shtml",
    "datetime": "2021-11-22 21:30:33",
    "code": "300294"
  },
  {
    "title": "博雅生物：股份协议转让完成 实控人变更为中国华润",
    "href": "http://stock.jrj.com.cn/2021/11/22201333905267.shtml",
    "datetime": "2021-11-22 20:13:21",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：拟使用不超9亿元闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/11/15193133855728.shtml",
    "datetime": "2021-11-15 19:31:30",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：拟使用不超30亿元闲置自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2021/11/15193033855727.shtml",
    "datetime": "2021-11-15 19:30:18",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：申请向特定对象发行股票获审核通过",
    "href": "http://stock.jrj.com.cn/2021/09/15202933441117.shtml",
    "datetime": "2021-09-15 20:29:46",
    "code": "300294"
  },
  {
    "title": "博雅生物股东增持32.44万股 耗资928.46万 上半年公司净利1.98亿",
    "href": "http://stock.jrj.com.cn/2021/09/07200533399892.shtml",
    "datetime": "2021-09-07 20:05:41",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：5名董事、高管完成增持32.44万股 共耗资928.46万元",
    "href": "http://stock.jrj.com.cn/2021/09/07173233399086.shtml",
    "datetime": "2021-09-07 17:32:06",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：拟将广东复大医药75%的股权转让给华润医商",
    "href": "http://stock.jrj.com.cn/2021/09/01203933369439.shtml",
    "datetime": "2021-09-01 20:39:56",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：委托华润医商对复大医药实进行管理",
    "href": "http://stock.jrj.com.cn/2021/09/01203833369438.shtml",
    "datetime": "2021-09-01 20:38:15",
    "code": "300294"
  },
  {
    "title": "博雅生物2021年半年度净利1.98亿元 同比净利增加22.72%",
    "href": "http://stock.jrj.com.cn/2021/08/26233533327883.shtml",
    "datetime": "2021-08-26 23:35:09",
    "code": "300294"
  },
  {
    "title": "A股异动 | 博雅生物(300294.SZ)跌5% 股东拟合计减持不超329.037万股",
    "href": "http://stock.jrj.com.cn/2021/08/11141233237103.shtml",
    "datetime": "2021-08-11 14:12:50",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：廖昕晰及其控制的企业拟合计减持不超329.0371万股",
    "href": "http://stock.jrj.com.cn/2021/08/10195833233351.shtml",
    "datetime": "2021-08-10 19:58:36",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：人血管性血友病因子获批临床",
    "href": "http://stock.jrj.com.cn/2021/08/06174033213488.shtml",
    "datetime": "2021-08-06 17:40:06",
    "code": "300294"
  },
  {
    "title": "【龙虎榜】博雅生物7月20日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/07/20180433125133.shtml",
    "datetime": "2021-07-20 18:04:30",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)涨停 定增恢复审核申请获深交所同意",
    "href": "http://stock.jrj.com.cn/2021/07/20103733123102.shtml",
    "datetime": "2021-07-20 10:37:31",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：收到深交所恢复审核通知 涉及定增事项",
    "href": "http://stock.jrj.com.cn/2021/07/19203133120635.shtml",
    "datetime": "2021-07-19 20:31:49",
    "code": "300294"
  },
  {
    "title": "博雅生物：股东高特佳集团所持合计7115.18万股解除质押",
    "href": "http://stock.jrj.com.cn/2021/07/16194233109009.shtml",
    "datetime": "2021-07-16 19:42:40",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：高特佳集团解除质押合计7115.1785万股",
    "href": "http://stock.jrj.com.cn/2021/07/16173733108256.shtml",
    "datetime": "2021-07-16 17:37:37",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：华润医药控股已完成受让公司16%的股份",
    "href": "http://stock.jrj.com.cn/2021/07/15214233103738.shtml",
    "datetime": "2021-07-15 21:42:41",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：拟转让所持有的罗益生物11.68%的股权",
    "href": "http://stock.jrj.com.cn/2021/07/08210133065998.shtml",
    "datetime": "2021-07-08 21:01:35",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：华润医药控股收购公司控制权获国务院国资委批复",
    "href": "http://stock.jrj.com.cn/2021/07/06200633054361.shtml",
    "datetime": "2021-07-06 20:06:48",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：柯菲平西他沙星片获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/29175633016712.shtml",
    "datetime": "2021-06-29 17:56:05",
    "code": "300294"
  },
  {
    "title": "博雅生物：生活水平的提高及物价上涨直接人工成本亦有所上升",
    "href": "http://stock.jrj.com.cn/2021/06/17214632950067.shtml",
    "datetime": "2021-06-17 21:46:11",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：5名董事、高管增持期过半 合计增持31.44万股",
    "href": "http://stock.jrj.com.cn/2021/06/10165332905590.shtml",
    "datetime": "2021-06-10 16:53:58",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：控股股东解押245万股",
    "href": "http://stock.jrj.com.cn/2021/05/30140132840947.shtml",
    "datetime": "2021-05-30 14:01:08",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：屯昌浆站获得单采血浆许可证",
    "href": "http://stock.jrj.com.cn/2021/05/25165932816970.shtml",
    "datetime": "2021-05-25 16:59:53",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：2020年度拟10派0.65元 股权登记日5月25日",
    "href": "http://stock.jrj.com.cn/2021/05/19220232783598.shtml",
    "datetime": "2021-05-19 22:02:03",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：深交所中止审核公司定增申请",
    "href": "http://stock.jrj.com.cn/2021/05/17120932768534.shtml",
    "datetime": "2021-05-17 12:09:50",
    "code": "300294"
  },
  {
    "title": "博雅生物股东融华投资减持112.79万股 套现3202.11万",
    "href": "http://stock.jrj.com.cn/2021/05/10195632731470.shtml",
    "datetime": "2021-05-10 19:56:27",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：减持期满 融华投资已减持112.79万股",
    "href": "http://stock.jrj.com.cn/2021/05/10160732729855.shtml",
    "datetime": "2021-05-10 16:07:57",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：收到深交所恢复审核通知 涉及定增事项",
    "href": "http://stock.jrj.com.cn/2021/05/07152132707968.shtml",
    "datetime": "2021-05-07 15:21:31",
    "code": "300294"
  },
  {
    "title": "博雅生物：公司向博雅（广东）采购原料血浆事项尚未获得监管部门的批复",
    "href": "http://stock.jrj.com.cn/2021/04/06181332320134.shtml",
    "datetime": "2021-04-06 18:13:25",
    "code": "300294"
  },
  {
    "title": "博雅生物：公司已收回收购罗益生物股权项目的款项",
    "href": "http://stock.jrj.com.cn/2021/04/02162732270781.shtml",
    "datetime": "2021-04-02 16:27:39",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：向博雅(广东)支付的采购原料血浆款项及相关利息已全额收回",
    "href": "http://stock.jrj.com.cn/2021/04/01131832262258.shtml",
    "datetime": "2021-04-01 13:18:33",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：控股股东所持公司股份解除司法冻结4935.1785万股",
    "href": "http://stock.jrj.com.cn/2021/03/25182832217292.shtml",
    "datetime": "2021-03-25 18:28:03",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：尚有采购原料血浆款项约6.71亿元及相关利息须返还给公司",
    "href": "http://stock.jrj.com.cn/2021/03/24180732209772.shtml",
    "datetime": "2021-03-24 18:07:18",
    "code": "300294"
  },
  {
    "title": "控股股东“宫斗”白热化 博雅生物易主生悬念",
    "href": "http://stock.jrj.com.cn/2021/03/11031032106396.shtml",
    "datetime": "2021-03-11 03:10:19",
    "code": "300294"
  },
  {
    "title": "宫斗太抢眼！起因于桃色风波，“最强原配”董事长宣布赶走前夫！这家公司彻底乱套了",
    "href": "http://stock.jrj.com.cn/2021/03/10194632105216.shtml",
    "datetime": "2021-03-10 19:46:50",
    "code": "300294"
  },
  {
    "title": "A股异动 | 博雅生物(300294.SZ)涨逾4% 部分董事及高管拟不超1100万元增持股份",
    "href": "http://stock.jrj.com.cn/2021/03/08101832089760.shtml",
    "datetime": "2021-03-08 10:18:11",
    "code": "300294"
  },
  {
    "title": "博雅生物：部分董事、高管计划以600万元-1100万元增持股份",
    "href": "http://stock.jrj.com.cn/2021/03/07180832084592.shtml",
    "datetime": "2021-03-07 18:08:30",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)部分董事及高管拟不超1100万元增持股份",
    "href": "http://stock.jrj.com.cn/2021/03/07174632084518.shtml",
    "datetime": "2021-03-07 17:46:01",
    "code": "300294"
  },
  {
    "title": "博雅生物“易主”或搁浅，控股股东高特佳自身暂不具备充分偿债能力",
    "href": "http://stock.jrj.com.cn/2021/03/05213332080424.shtml",
    "datetime": "2021-03-05 21:33:09",
    "code": "300294"
  },
  {
    "title": "A股异动 | 博雅生物(300294.SZ)一度跌超9% 公司股票可能被实施其他风险警示",
    "href": "http://stock.jrj.com.cn/2021/03/05095332076650.shtml",
    "datetime": "2021-03-05 09:53:10",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：公司股票交易可能被实施其他风险警示",
    "href": "http://stock.jrj.com.cn/2021/03/04204632072994.shtml",
    "datetime": "2021-03-04 20:46:56",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：新兴生物减持期届满 未减持公司股份",
    "href": "http://stock.jrj.com.cn/2021/03/01165232050885.shtml",
    "datetime": "2021-03-01 16:52:07",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：融华投资减持期过半 尚未减持公司股份",
    "href": "http://stock.jrj.com.cn/2021/02/18164731987083.shtml",
    "datetime": "2021-02-18 16:47:02",
    "code": "300294"
  },
  {
    "title": "博雅生物1亿股遭冻结 深交所:高特佳是否侵害公司利益",
    "href": "http://stock.jrj.com.cn/2021/02/18163731987003.shtml",
    "datetime": "2021-02-18 16:37:00",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：深交所中止审核公司定增申请",
    "href": "http://stock.jrj.com.cn/2021/02/09171531878065.shtml",
    "datetime": "2021-02-09 17:15:43",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：聘任梁小明担任公司总经理",
    "href": "http://stock.jrj.com.cn/2021/02/04200231850508.shtml",
    "datetime": "2021-02-04 20:02:23",
    "code": "300294"
  },
  {
    "title": "博雅生物控股股东遭通报批评 持股比例降10%信披违规",
    "href": "http://stock.jrj.com.cn/2021/01/29171431810167.shtml",
    "datetime": "2021-01-29 17:14:00",
    "code": "300294"
  },
  {
    "title": "博雅生物控股股东高特佳集团大手笔抛售股票未按规定停牌 被通报批评",
    "href": "http://stock.jrj.com.cn/2021/01/29103131807449.shtml",
    "datetime": "2021-01-29 10:31:00",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：控股股东解除质押及质押1180万股",
    "href": "http://stock.jrj.com.cn/2021/01/22182831746441.shtml",
    "datetime": "2021-01-22 18:28:15",
    "code": "300294"
  },
  {
    "title": "博雅生物控股股东高特佳集团质押1300万股 用于融资",
    "href": "http://stock.jrj.com.cn/2021/01/20212331731432.shtml",
    "datetime": "2021-01-20 21:23:33",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：控股股东质押1300万股",
    "href": "http://stock.jrj.com.cn/2021/01/20193431730741.shtml",
    "datetime": "2021-01-20 19:34:22",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：华润医药控股收购公司股权案通过反垄断审查",
    "href": "http://stock.jrj.com.cn/2021/01/19172131722637.shtml",
    "datetime": "2021-01-19 17:21:56",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：定增申请获深交所受理",
    "href": "http://stock.jrj.com.cn/2021/01/04202431629055.shtml",
    "datetime": "2021-01-04 20:24:47",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：博雅(广东)累计向公司返还1亿元",
    "href": "http://stock.jrj.com.cn/2020/12/31183831613819.shtml",
    "datetime": "2020-12-31 18:38:34",
    "code": "300294"
  },
  {
    "title": "博雅生物股东范一沁减持29.59万股 套现约1139.51万元",
    "href": "http://stock.jrj.com.cn/2020/12/11193431466704.shtml",
    "datetime": "2020-12-11 19:34:56",
    "code": "300294"
  },
  {
    "title": "[博雅生物]赞!博雅生物派员参加全国“两法”知识竞赛荣获三等奖",
    "href": "http://stock.jrj.com.cn/2020/12/11000031464440.shtml",
    "datetime": "2020-12-11 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：获得“人凝血酶原复合物”《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2020/12/08170531440978.shtml",
    "datetime": "2020-12-08 17:05:27",
    "code": "300294"
  },
  {
    "title": "博雅生物2020年前三季度净利2.24亿减少29.69% 理财产品收益减少",
    "href": "http://stock.jrj.com.cn/2020/11/01161931184071.shtml",
    "datetime": "2020-11-01 16:19:08",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物第四届职工运动会正式拉开序幕!",
    "href": "http://stock.jrj.com.cn/2020/10/27000031141178.shtml",
    "datetime": "2020-10-27 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物第四届职工运动会今日拉开序幕!",
    "href": "http://stock.jrj.com.cn/2020/10/27000031141179.shtml",
    "datetime": "2020-10-27 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物在中国输血协会第十届输血大会作交流发言",
    "href": "http://stock.jrj.com.cn/2020/10/23000031116733.shtml",
    "datetime": "2020-10-23 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]热烈祝贺博雅生物制药集团新百药业荣登“2020中国化学制药行业优秀企业和优秀产品品牌榜”!",
    "href": "http://stock.jrj.com.cn/2020/10/23000031130823.shtml",
    "datetime": "2020-10-23 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]热烈祝贺博雅生物制药集团新百药业荣登“2020中国化学制药行业优秀企业和优秀产品品牌榜”!",
    "href": "http://stock.jrj.com.cn/2020/10/23000031116732.shtml",
    "datetime": "2020-10-23 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：博雅(广东)与公司等签订委托管理经营框架协议",
    "href": "http://stock.jrj.com.cn/2020/10/19145131083447.shtml",
    "datetime": "2020-10-19 14:51:48",
    "code": "300294"
  },
  {
    "title": "1亿变60亿 高特佳收网",
    "href": "http://stock.jrj.com.cn/2020/10/16103631066180.shtml",
    "datetime": "2020-10-16 10:36:35",
    "code": "300294"
  },
  {
    "title": "博雅生物股权转让收关注函 关联方7.6亿元债务清偿没",
    "href": "http://stock.jrj.com.cn/2020/10/12155731032359.shtml",
    "datetime": "2020-10-12 15:57:00",
    "code": "300294"
  },
  {
    "title": "退意已决！博雅生物“易主” 一场婚外情引发的颓势？",
    "href": "http://stock.jrj.com.cn/2020/10/10185131016434.shtml",
    "datetime": "2020-10-10 18:51:21",
    "code": "300294"
  },
  {
    "title": "A股异动 | 博雅生物(300294.SZ)复牌涨超7% 华润医药控股将成为公司控股股东",
    "href": "http://stock.jrj.com.cn/2020/10/09142631010146.shtml",
    "datetime": "2020-10-09 14:26:17",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：因采购原料血浆而形成控股股东关联方经营性往来解决方案",
    "href": "http://stock.jrj.com.cn/2020/09/30211130869052.shtml",
    "datetime": "2020-09-30 21:11:50",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)：华润医药控股将成为公司控股股东 10月9日起复牌",
    "href": "http://stock.jrj.com.cn/2020/09/30210430869054.shtml",
    "datetime": "2020-09-30 21:04:49",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)拟向华润医药控股发行股份募资不超27.24亿元",
    "href": "http://stock.jrj.com.cn/2020/09/30210230869056.shtml",
    "datetime": "2020-09-30 21:02:27",
    "code": "300294"
  },
  {
    "title": "华润医药拟28亿“笑纳”博雅生物控制权 旗下8家上市公司形成完整大健康产业链",
    "href": "http://stock.jrj.com.cn/2020/09/29074430857717.shtml",
    "datetime": "2020-09-29 07:44:31",
    "code": "300294"
  },
  {
    "title": "退意已决！博雅生物“易主” 一场婚外情引发的颓势？",
    "href": "http://stock.jrj.com.cn/2020/09/29072631036039.shtml",
    "datetime": "2020-09-29 07:26:00",
    "code": "300294"
  },
  {
    "title": "退意已决！博雅生物“易主” 一场婚外情引发的颓势？",
    "href": "http://stock.jrj.com.cn/2020/09/29072630857742.shtml",
    "datetime": "2020-09-29 07:26:00",
    "code": "300294"
  },
  {
    "title": "董事长被曝出轨后 高特佳向华润医药转让博雅生物控制权",
    "href": "http://stock.jrj.com.cn/2020/09/28172930854159.shtml",
    "datetime": "2020-09-28 17:29:23",
    "code": "300294"
  },
  {
    "title": "关于博雅生物制药集团股份有限公司股票临时停牌的公告",
    "href": "http://stock.jrj.com.cn/2020/09/28151030853342.shtml",
    "datetime": "2020-09-28 15:10:00",
    "code": "300294"
  },
  {
    "title": "持股高特佳近56%却否认实控 博雅生物乱象凸显私募控股困局",
    "href": "http://stock.jrj.com.cn/2020/09/15080130752504.shtml",
    "datetime": "2020-09-15 08:01:57",
    "code": "300294"
  },
  {
    "title": "持股高特佳近56%却否认实控博雅生物 乱象凸显私募控股困局",
    "href": "http://stock.jrj.com.cn/2020/09/15024330750749.shtml",
    "datetime": "2020-09-15 02:43:52",
    "code": "300294"
  },
  {
    "title": "博雅生物：向博雅广东采购原料血浆或存在重大不确定性",
    "href": "http://stock.jrj.com.cn/2020/09/14212130749819.shtml",
    "datetime": "2020-09-14 21:21:32",
    "code": "300294"
  },
  {
    "title": "博雅生物(300294.SZ)控股股东董事长回复深交所问询函：其本人不是公司实控人，亦不存在实际控制公司情形",
    "href": "http://stock.jrj.com.cn/2020/09/14091030745263.shtml",
    "datetime": "2020-09-14 09:10:20",
    "code": "300294"
  },
  {
    "title": "高特佳董事长“家丑”引发博雅生物“8亿元”输血风波",
    "href": "http://stock.jrj.com.cn/2020/09/12073830734242.shtml",
    "datetime": "2020-09-12 07:38:30",
    "code": "300294"
  },
  {
    "title": "高特佳蔡达建被妻子“举报”：博雅生物被卷入 股权转让或受影响",
    "href": "http://stock.jrj.com.cn/2020/09/11204330732293.shtml",
    "datetime": "2020-09-11 20:43:31",
    "code": "300294"
  },
  {
    "title": "博雅生物股东懿康投资减持1468.52万股 套现约5.56亿元",
    "href": "http://stock.jrj.com.cn/2020/09/04204130678753.shtml",
    "datetime": "2020-09-04 20:41:33",
    "code": "300294"
  },
  {
    "title": "博雅生物2020年上半年净利1.61亿下滑24.42% 产品综合毛利率有所下降",
    "href": "http://stock.jrj.com.cn/2020/08/27110930602695.shtml",
    "datetime": "2020-08-27 11:09:42",
    "code": "300294"
  },
  {
    "title": "无资质停产仍付预付款8亿多 博雅生物谜一般的关联交易遭问询",
    "href": "http://stock.jrj.com.cn/2020/08/19073230534971.shtml",
    "datetime": "2020-08-19 07:32:04",
    "code": "300294"
  },
  {
    "title": "博雅生物董事长及其控制企业合计减持548万股 套现合计约2.57亿元",
    "href": "http://stock.jrj.com.cn/2020/07/27205430357135.shtml",
    "datetime": "2020-07-27 20:54:42",
    "code": "300294"
  },
  {
    "title": "超8亿“奇葩”关联交易遭问询！博雅生物控股股东却要撤退",
    "href": "http://stock.jrj.com.cn/2020/07/07071430161375.shtml",
    "datetime": "2020-07-07 07:14:01",
    "code": "300294"
  },
  {
    "title": "【龙虎榜】博雅生物7月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/06180630155008.shtml",
    "datetime": "2020-07-06 18:06:11",
    "code": "300294"
  },
  {
    "title": "快讯：博雅生物急速拉升8.70% 主力资金净流入2553.21万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/06100130150684.shtml",
    "datetime": "2020-07-06 10:01:12",
    "code": "300294"
  },
  {
    "title": "博雅生物：控股股东正筹划涉及公司股权变动的重大事项",
    "href": "http://stock.jrj.com.cn/2020/07/06080530149374.shtml",
    "datetime": "2020-07-06 08:05:40",
    "code": "300294"
  },
  {
    "title": "【龙虎榜】博雅生物7月3日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/03180630135594.shtml",
    "datetime": "2020-07-03 18:06:13",
    "code": "300294"
  },
  {
    "title": "快讯：博雅生物急速拉升6.33% 主力资金净流入5407.42万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/03100430131048.shtml",
    "datetime": "2020-07-03 10:04:01",
    "code": "300294"
  },
  {
    "title": "8亿元预付款养肥关联方 谁在遥控博雅生物“吃里扒外”？",
    "href": "http://stock.jrj.com.cn/2020/07/03072430129407.shtml",
    "datetime": "2020-07-03 07:24:36",
    "code": "300294"
  },
  {
    "title": "快讯：博雅生物急速拉升5.71% 主力资金净流入2945.85万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/02094130119045.shtml",
    "datetime": "2020-07-02 09:41:34",
    "code": "300294"
  },
  {
    "title": "3年预付8亿元却无货可交 博雅生物异常关联交易肥了谁？",
    "href": "http://stock.jrj.com.cn/2020/07/01075230106633.shtml",
    "datetime": "2020-07-01 07:52:50",
    "code": "300294"
  },
  {
    "title": "3年预付8亿元却无货可交 博雅生物异常关联交易肥了谁？",
    "href": "http://stock.jrj.com.cn/2020/07/01074830106629.shtml",
    "datetime": "2020-07-01 07:48:58",
    "code": "300294"
  },
  {
    "title": "博雅生物8亿关联交易预付款遭问询 关联方停产一年多",
    "href": "http://stock.jrj.com.cn/2020/06/29131030085890.shtml",
    "datetime": "2020-06-29 13:10:00",
    "code": "300294"
  },
  {
    "title": "博雅生物股东梁小明减持18.6万股 套现约730.61万元",
    "href": "http://stock.jrj.com.cn/2020/06/24204330012171.shtml",
    "datetime": "2020-06-24 20:43:33",
    "code": "300294"
  },
  {
    "title": "[博雅生物]喜讯!博雅生物制药集团获批设置海南屯昌单采血浆站",
    "href": "http://stock.jrj.com.cn/2020/05/21000029728828.shtml",
    "datetime": "2020-05-21 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物2名股东拟减持股份 预计合计减持不超总股本0.11%",
    "href": "http://stock.jrj.com.cn/2020/05/20214829724358.shtml",
    "datetime": "2020-05-20 21:48:38",
    "code": "300294"
  },
  {
    "title": "博雅生物获批设置单采血浆站",
    "href": "http://stock.jrj.com.cn/2020/05/20195029723650.shtml",
    "datetime": "2020-05-20 19:50:02",
    "code": "300294"
  },
  {
    "title": "博雅生物股东高特佳集团质押245万股 用于自身经营",
    "href": "http://stock.jrj.com.cn/2020/05/19222929714690.shtml",
    "datetime": "2020-05-19 22:29:12",
    "code": "300294"
  },
  {
    "title": "[博雅生物]热烈祝贺博雅生物第五届职工(会员)代表大会暨换届选举大会顺利召开",
    "href": "http://stock.jrj.com.cn/2020/05/18000029699733.shtml",
    "datetime": "2020-05-18 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物职工代表监事姜国亮辞职 2019年薪酬为37.5万元",
    "href": "http://stock.jrj.com.cn/2020/05/17192329691661.shtml",
    "datetime": "2020-05-17 19:23:18",
    "code": "300294"
  },
  {
    "title": "博雅生物：持股5.1427%股东拟合计减持不超1.2857%股份",
    "href": "http://stock.jrj.com.cn/2020/05/15210429684052.shtml",
    "datetime": "2020-05-15 21:04:28",
    "code": "300294"
  },
  {
    "title": "博雅生物股东新兴生物减持853.27万股 套现约2.63亿元",
    "href": "http://stock.jrj.com.cn/2020/05/11201429643199.shtml",
    "datetime": "2020-05-11 20:14:44",
    "code": "300294"
  },
  {
    "title": "博雅生物第一季度盈利9590.05万 较上年同期增长7.51%",
    "href": "http://stock.jrj.com.cn/2020/05/02120329458959.shtml",
    "datetime": "2020-05-02 12:03:30",
    "code": "300294"
  },
  {
    "title": "博雅生物2019年净利4.26亿减少9% 董事长廖昕晰薪酬320万元",
    "href": "http://stock.jrj.com.cn/2020/04/30191329434177.shtml",
    "datetime": "2020-04-30 19:13:19",
    "code": "300294"
  },
  {
    "title": "博雅生物：终止购买无锡罗益（无锡）生物制药48.87%股权",
    "href": "http://stock.jrj.com.cn/2020/04/20222029331900.shtml",
    "datetime": "2020-04-20 22:20:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：控股股东一致行动人懿康投资拟清仓减持",
    "href": "http://stock.jrj.com.cn/2020/04/09071429242021.shtml",
    "datetime": "2020-04-09 07:14:00",
    "code": "300294"
  },
  {
    "title": "博雅生物股东懿康投资拟减持股份 预计减持不超总股本3.45%",
    "href": "http://stock.jrj.com.cn/2020/04/08231229240260.shtml",
    "datetime": "2020-04-08 23:12:15",
    "code": "300294"
  },
  {
    "title": "博雅生物：控股股东一致行动人拟减持不超3.4477%股份",
    "href": "http://stock.jrj.com.cn/2020/04/08212629239534.shtml",
    "datetime": "2020-04-08 21:26:11",
    "code": "300294"
  },
  {
    "title": "博雅生物：子公司产品格列美脲片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/04/06195529214683.shtml",
    "datetime": "2020-04-06 19:55:19",
    "code": "300294"
  },
  {
    "title": "博雅生物：控股子公司产品格列美脲片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/04/06172129213918.shtml",
    "datetime": "2020-04-06 17:21:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]英雄凯旋!隐形战士博雅生物吴骁,在核酸实验室构筑抗疫防线!",
    "href": "http://stock.jrj.com.cn/2020/03/20000029067271.shtml",
    "datetime": "2020-03-20 00:00:00",
    "code": "300294"
  },
  {
    "title": "29家公司率先预告首季业绩 8家净利润有望实现翻番",
    "href": "http://stock.jrj.com.cn/2020/03/05234228961941.shtml",
    "datetime": "2020-03-05 23:42:12",
    "code": "300294"
  },
  {
    "title": "博雅生物2019年净利润4.25亿元下滑9.45% 销售费用等期间费用增长",
    "href": "http://stock.jrj.com.cn/2020/02/28225328917852.shtml",
    "datetime": "2020-02-28 22:53:23",
    "code": "300294"
  },
  {
    "title": "鼠年首个被否并购案 博雅生物涉高溢价关联交易",
    "href": "http://stock.jrj.com.cn/2020/02/25073728887102.shtml",
    "datetime": "2020-02-25 07:37:16",
    "code": "300294"
  },
  {
    "title": "高溢价收购被否 博雅生物重组期股东减持未停歇",
    "href": "http://stock.jrj.com.cn/2020/02/23095728876313.shtml",
    "datetime": "2020-02-23 09:57:09",
    "code": "300294"
  },
  {
    "title": "高溢价收购被否 博雅生物重组期股东减持未停歇",
    "href": "http://stock.jrj.com.cn/2020/02/22092528874761.shtml",
    "datetime": "2020-02-22 09:25:14",
    "code": "300294"
  },
  {
    "title": "鼠年首家重组被否 博雅生物怎么了",
    "href": "http://stock.jrj.com.cn/2020/02/19012728851187.shtml",
    "datetime": "2020-02-19 01:27:50",
    "code": "300294"
  },
  {
    "title": "公告精选：方正集团被申请重整；一汽轿车重组获通过，博雅生物重组被否",
    "href": "http://stock.jrj.com.cn/2020/02/18212528850588.shtml",
    "datetime": "2020-02-18 21:25:00",
    "code": "300294"
  },
  {
    "title": "博雅生物拟控股罗益生物落空 为鼠年首家重组被否企业",
    "href": "http://stock.jrj.com.cn/2020/02/18204928850465.shtml",
    "datetime": "2020-02-18 20:49:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：关于公司股票复牌的公告",
    "href": "http://stock.jrj.com.cn/2020/02/18202028850240.shtml",
    "datetime": "2020-02-18 20:20:00",
    "code": "300294"
  },
  {
    "title": "博雅生物重组事项未获通过 公司股票19日复牌",
    "href": "http://stock.jrj.com.cn/2020/02/18184028849617.shtml",
    "datetime": "2020-02-18 18:40:30",
    "code": "300294"
  },
  {
    "title": "博雅生物：重组未获通过 明日复牌",
    "href": "http://stock.jrj.com.cn/2020/02/18182028849531.shtml",
    "datetime": "2020-02-18 18:20:05",
    "code": "300294"
  },
  {
    "title": "博雅生物重组事项未获证监会审核通过 19日起复牌",
    "href": "http://stock.jrj.com.cn/2020/02/18181828849526.shtml",
    "datetime": "2020-02-18 18:18:06",
    "code": "300294"
  },
  {
    "title": "博雅生物：重组未获通过 19日复牌",
    "href": "http://stock.jrj.com.cn/2020/02/18181328849510.shtml",
    "datetime": "2020-02-18 18:13:20",
    "code": "300294"
  },
  {
    "title": "博雅生物：重组未获通过 明起复牌",
    "href": "http://stock.jrj.com.cn/2020/02/18180428849477.shtml",
    "datetime": "2020-02-18 18:04:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：停牌公告",
    "href": "http://stock.jrj.com.cn/2020/02/17205028841061.shtml",
    "datetime": "2020-02-17 20:50:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：重组上会 股票停牌",
    "href": "http://stock.jrj.com.cn/2020/02/17180628840085.shtml",
    "datetime": "2020-02-17 18:06:35",
    "code": "300294"
  },
  {
    "title": "博雅生物：重组即将上会 18日股票停牌",
    "href": "http://stock.jrj.com.cn/2020/02/17171528839816.shtml",
    "datetime": "2020-02-17 17:15:00",
    "code": "300294"
  },
  {
    "title": "博雅生物重组事项将上会 18日停牌",
    "href": "http://stock.jrj.com.cn/2020/02/17170628839769.shtml",
    "datetime": "2020-02-17 17:06:14",
    "code": "300294"
  },
  {
    "title": "博雅生物：证监会并购重组委审核公司发行股份等事项 18日起停牌",
    "href": "http://stock.jrj.com.cn/2020/02/17165328839695.shtml",
    "datetime": "2020-02-17 16:53:17",
    "code": "300294"
  },
  {
    "title": "鼠年首场重组审核 博雅生物、一汽轿车18日上会",
    "href": "http://stock.jrj.com.cn/2020/02/14013728826284.shtml",
    "datetime": "2020-02-14 01:37:06",
    "code": "300294"
  },
  {
    "title": "证监会：一汽轿车、博雅生物发行股份购买资产事项2月18日上会",
    "href": "http://stock.jrj.com.cn/2020/02/12184628816849.shtml",
    "datetime": "2020-02-12 18:46:00",
    "code": "300294"
  },
  {
    "title": "证监会将于2月18日审议一汽、博雅生物购买资产事项",
    "href": "http://stock.jrj.com.cn/2020/02/12184428816811.shtml",
    "datetime": "2020-02-12 18:44:01",
    "code": "300294"
  },
  {
    "title": "爆棚！300多家机构调研这只抗疫概念股 透露产品抗疫特殊疗效",
    "href": "http://stock.jrj.com.cn/2020/02/09204828798705.shtml",
    "datetime": "2020-02-09 20:48:45",
    "code": "300294"
  },
  {
    "title": "博雅生物：预计今年全国血浆总量可能有所下降",
    "href": "http://stock.jrj.com.cn/2020/02/05100028774204.shtml",
    "datetime": "2020-02-05 10:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/02/02231028749671.shtml",
    "datetime": "2020-02-02 23:10:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/02/02231028749670.shtml",
    "datetime": "2020-02-02 23:10:00",
    "code": "300294"
  },
  {
    "title": "博雅生物2019年预计净利3.99亿元—4.69亿元",
    "href": "http://stock.jrj.com.cn/2020/02/02191928749130.shtml",
    "datetime": "2020-02-02 19:19:04",
    "code": "300294"
  },
  {
    "title": "博雅生物：不计成本发送药品到疫情重灾区",
    "href": "http://stock.jrj.com.cn/2020/01/27142028737693.shtml",
    "datetime": "2020-01-27 14:20:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]“鼠”你最棒|致2019可爱博雅人",
    "href": "http://stock.jrj.com.cn/2020/01/19000028979495.shtml",
    "datetime": "2020-01-19 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]“鼠”你最棒|致2019可爱博雅人",
    "href": "http://stock.jrj.com.cn/2020/01/19000030406628.shtml",
    "datetime": "2020-01-19 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]“鼠”你最棒|致2019可爱博雅人",
    "href": "http://stock.jrj.com.cn/2020/01/19000031004505.shtml",
    "datetime": "2020-01-19 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]“鼠”你最棒|致2019可爱博雅人",
    "href": "http://stock.jrj.com.cn/2020/01/19000028703191.shtml",
    "datetime": "2020-01-19 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物收购罗益生物,启动血液制品+疫苗战略",
    "href": "http://stock.jrj.com.cn/2019/12/26000028589526.shtml",
    "datetime": "2019-12-26 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物收购罗益生物,启动血液制品+疫苗战略",
    "href": "http://stock.jrj.com.cn/2019/12/26000030102657.shtml",
    "datetime": "2019-12-26 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物收购罗益生物,启动血液制品+疫苗战略",
    "href": "http://stock.jrj.com.cn/2019/12/26000031004499.shtml",
    "datetime": "2019-12-26 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物收购罗益生物,启动血液制品+疫苗战略",
    "href": "http://stock.jrj.com.cn/2019/12/26000031824305.shtml",
    "datetime": "2019-12-26 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：公司拟以发行股份和可转债及现金方式购买罗益生物48.87％股权",
    "href": "http://stock.jrj.com.cn/2019/12/23215828574691.shtml",
    "datetime": "2019-12-23 21:58:07",
    "code": "300294"
  },
  {
    "title": "业绩增长放缓 博雅生物不惜1.75亿元现金收购罗益生物",
    "href": "http://stock.jrj.com.cn/2019/12/23085628570901.shtml",
    "datetime": "2019-12-23 08:56:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物组织血液制品实验室管理与技术培训",
    "href": "http://stock.jrj.com.cn/2019/12/12000031004500.shtml",
    "datetime": "2019-12-12 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物组织血液制品实验室管理与技术培训",
    "href": "http://stock.jrj.com.cn/2019/12/12000031824304.shtml",
    "datetime": "2019-12-12 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物组织血液制品实验室管理与技术培训",
    "href": "http://stock.jrj.com.cn/2019/12/12000028523582.shtml",
    "datetime": "2019-12-12 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物组织血液制品实验室管理与技术培训",
    "href": "http://stock.jrj.com.cn/2019/12/12000028979497.shtml",
    "datetime": "2019-12-12 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物组织血液制品实验室管理与技术培训",
    "href": "http://stock.jrj.com.cn/2019/12/12000030102656.shtml",
    "datetime": "2019-12-12 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物股东懿康投资减持463万股 套现约1.45亿元",
    "href": "http://stock.jrj.com.cn/2019/11/22092328436069.shtml",
    "datetime": "2019-11-22 09:23:46",
    "code": "300294"
  },
  {
    "title": "博雅生物股东范一沁拟减持股份 预计减持不超总股本0.42%",
    "href": "http://stock.jrj.com.cn/2019/11/15183228405858.shtml",
    "datetime": "2019-11-15 18:32:49",
    "code": "300294"
  },
  {
    "title": "博雅生物：董秘拟减持不超0.42%股份",
    "href": "http://stock.jrj.com.cn/2019/11/15161028405054.shtml",
    "datetime": "2019-11-15 16:10:51",
    "code": "300294"
  },
  {
    "title": "[博雅生物]喜讯|博雅生物荣获“2018年度金牛最具投资价值奖”",
    "href": "http://stock.jrj.com.cn/2019/11/01000031004498.shtml",
    "datetime": "2019-11-01 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]喜讯|博雅生物荣获“2018年度金牛最具投资价值奖”",
    "href": "http://stock.jrj.com.cn/2019/11/01000028337533.shtml",
    "datetime": "2019-11-01 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]喜讯|博雅生物荣获“2018年度金牛最具投资价值奖”",
    "href": "http://stock.jrj.com.cn/2019/11/01000029809992.shtml",
    "datetime": "2019-11-01 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]新面貌 新征程|博雅生物正式启用全新品牌标志",
    "href": "http://stock.jrj.com.cn/2019/10/25000028299937.shtml",
    "datetime": "2019-10-25 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]新面貌 新征程|博雅生物正式启用全新品牌标志",
    "href": "http://stock.jrj.com.cn/2019/10/25000028979500.shtml",
    "datetime": "2019-10-25 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]新面貌 新征程|博雅生物正式启用全新品牌标志",
    "href": "http://stock.jrj.com.cn/2019/10/25000031004509.shtml",
    "datetime": "2019-10-25 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]新面貌 新征程|博雅生物正式启用全新品牌标志",
    "href": "http://stock.jrj.com.cn/2019/10/25000031381400.shtml",
    "datetime": "2019-10-25 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]新面貌 新征程|博雅生物正式启用全新品牌标志",
    "href": "http://stock.jrj.com.cn/2019/10/25000029592521.shtml",
    "datetime": "2019-10-25 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：公司暂无类似抑制肿瘤机制研究计划",
    "href": "http://stock.jrj.com.cn/2019/10/24144228293938.shtml",
    "datetime": "2019-10-24 14:42:59",
    "code": "300294"
  },
  {
    "title": "博雅生物股东新兴生物拟减持股份 预计减持不超总股本2.5%",
    "href": "http://stock.jrj.com.cn/2019/10/18213028269651.shtml",
    "datetime": "2019-10-18 21:30:31",
    "code": "300294"
  },
  {
    "title": "博雅生物：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/11222028235505.shtml",
    "datetime": "2019-10-11 22:20:00",
    "code": "300294"
  },
  {
    "title": "博雅生物股东廖昕晰质押136万股 2019年上半年净利同比增长12%",
    "href": "http://stock.jrj.com.cn/2019/10/11184228234639.shtml",
    "datetime": "2019-10-11 18:42:57",
    "code": "300294"
  },
  {
    "title": "博雅生物2019年前三季度净利约3.01亿元—3.29亿元 血液制品业务稳定增长",
    "href": "http://stock.jrj.com.cn/2019/10/11184028234628.shtml",
    "datetime": "2019-10-11 18:40:49",
    "code": "300294"
  },
  {
    "title": "医药股回调 机构净卖出华东医药、博雅生物",
    "href": "http://stock.jrj.com.cn/2019/08/28164228049612.shtml",
    "datetime": "2019-08-28 16:42:00",
    "code": "300294"
  },
  {
    "title": "博雅生物2019年上半年盈利2.1亿 血液制品业务同比增长",
    "href": "http://stock.jrj.com.cn/2019/08/28103128047634.shtml",
    "datetime": "2019-08-28 10:31:18",
    "code": "300294"
  },
  {
    "title": "博雅生物：药品人凝血酶原复合物纳入优先审评程序",
    "href": "http://stock.jrj.com.cn/2019/08/15203727983205.shtml",
    "datetime": "2019-08-15 20:37:38",
    "code": "300294"
  },
  {
    "title": "博雅生物：人凝血酶原复合物纳入优先审评程序",
    "href": "http://stock.jrj.com.cn/2019/08/15200827983128.shtml",
    "datetime": "2019-08-15 20:08:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：人凝血酶原复合物申报生产注册获国家药监局受理",
    "href": "http://stock.jrj.com.cn/2019/06/26205727760170.shtml",
    "datetime": "2019-06-26 20:57:44",
    "code": "300294"
  },
  {
    "title": "博雅生物：人凝血酶原复合物申报生产注册获受理",
    "href": "http://stock.jrj.com.cn/2019/06/26205227760137.shtml",
    "datetime": "2019-06-26 20:52:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：拟收购罗益生物60.55%股权 主业延伸至疫苗领域",
    "href": "http://stock.jrj.com.cn/2019/06/25210127754662.shtml",
    "datetime": "2019-06-25 21:01:16",
    "code": "300294"
  },
  {
    "title": "博雅生物：拟收购罗益生物60.55%股权",
    "href": "http://stock.jrj.com.cn/2019/06/25203227754535.shtml",
    "datetime": "2019-06-25 20:32:00",
    "code": "300294"
  },
  {
    "title": "博雅生物股东高特佳集团质押467万股 公司去年净利同比增长32%",
    "href": "http://stock.jrj.com.cn/2019/06/15174227708596.shtml",
    "datetime": "2019-06-15 17:42:49",
    "code": "300294"
  },
  {
    "title": "博雅生物：筹划重大资产重组 12日起停牌",
    "href": "http://stock.jrj.com.cn/2019/06/11212927688134.shtml",
    "datetime": "2019-06-11 21:29:18",
    "code": "300294"
  },
  {
    "title": "博雅生物：拟收购罗益生物不低于51%股权",
    "href": "http://stock.jrj.com.cn/2019/06/11204827688053.shtml",
    "datetime": "2019-06-11 20:48:13",
    "code": "300294"
  },
  {
    "title": "博雅生物：拟收购罗益生物不低于51%股权 明起停牌",
    "href": "http://stock.jrj.com.cn/2019/06/11200627687971.shtml",
    "datetime": "2019-06-11 20:06:00",
    "code": "300294"
  },
  {
    "title": "博雅生物股东高特佳集团质押110万股 去年营收同比增长68%",
    "href": "http://stock.jrj.com.cn/2019/06/05080027665729.shtml",
    "datetime": "2019-06-05 08:00:30",
    "code": "300294"
  },
  {
    "title": "神州高铁：董事长王志全减持公司2000万股",
    "href": "http://stock.jrj.com.cn/2019/05/22212127608882.shtml",
    "datetime": "2019-05-22 21:21:56",
    "code": "300294"
  },
  {
    "title": "博雅生物：全资孙公司产品获美国FDA批准",
    "href": "http://stock.jrj.com.cn/2019/05/22211427608850.shtml",
    "datetime": "2019-05-22 21:14:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：孙公司产品获得美国FDA批准",
    "href": "http://stock.jrj.com.cn/2019/05/22172827608012.shtml",
    "datetime": "2019-05-22 17:28:02",
    "code": "300294"
  },
  {
    "title": "博雅生物股东徐建新增持4500股 耗资13万元",
    "href": "http://stock.jrj.com.cn/2019/05/11192227557360.shtml",
    "datetime": "2019-05-11 19:22:21",
    "code": "300294"
  },
  {
    "title": "博雅生物：董事徐建新增持4500股",
    "href": "http://stock.jrj.com.cn/2019/05/10174027554824.shtml",
    "datetime": "2019-05-10 17:40:31",
    "code": "300294"
  },
  {
    "title": "博雅生物：公司董事徐建新5月10日增持4500股",
    "href": "http://stock.jrj.com.cn/2019/05/10171627554670.shtml",
    "datetime": "2019-05-10 17:16:12",
    "code": "300294"
  },
  {
    "title": "博雅生物：关于非公开发行限售股份解除限售的提示性公告",
    "href": "http://stock.jrj.com.cn/2019/04/16213027408922.shtml",
    "datetime": "2019-04-16 21:30:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/10000027356806.shtml",
    "datetime": "2019-04-10 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物一季度净利润预增15%-35%",
    "href": "http://stock.jrj.com.cn/2019/04/09190127355868.shtml",
    "datetime": "2019-04-09 19:01:59",
    "code": "300294"
  },
  {
    "title": "博雅生物：持股7.66%的股东懿康投资拟减持不超3%",
    "href": "http://stock.jrj.com.cn/2019/03/19181927192527.shtml",
    "datetime": "2019-03-19 18:19:01",
    "code": "300294"
  },
  {
    "title": "博雅生物：股东拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/03/19181827192549.shtml",
    "datetime": "2019-03-19 18:18:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：盐酸二甲双胍片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/hotstock/2019/02/20075927064963.shtml",
    "datetime": "2019-02-20 07:59:58",
    "code": "300294"
  },
  {
    "title": "博雅生物：公司盐酸二甲双胍片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/02/19172527063013.shtml",
    "datetime": "2019-02-19 17:25:44",
    "code": "300294"
  },
  {
    "title": "博雅生物控股子公司药品盐酸二甲双胍片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/02/19172127063012.shtml",
    "datetime": "2019-02-19 17:21:44",
    "code": "300294"
  },
  {
    "title": "博雅生物：控股子公司药品盐酸二甲双胍片通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2019/02/19170927062934.shtml",
    "datetime": "2019-02-19 17:09:00",
    "code": "300294"
  },
  {
    "title": "博雅生物股东新兴生物补充质押110万股 其持有47%被质押",
    "href": "http://stock.jrj.com.cn/2019/02/14231727045304.shtml",
    "datetime": "2019-02-14 23:17:27",
    "code": "300294"
  },
  {
    "title": "博雅生物2018年净利4.68亿元增长31% 广东复大被纳入合并报表",
    "href": "http://stock.jrj.com.cn/2019/02/12230427035824.shtml",
    "datetime": "2019-02-12 23:04:41",
    "code": "300294"
  },
  {
    "title": "博雅生物2018年度净利润同比增长31.26%",
    "href": "http://stock.jrj.com.cn/2019/02/12182727035063.shtml",
    "datetime": "2019-02-12 18:27:04",
    "code": "300294"
  },
  {
    "title": "博雅生物业绩快报：2018年净利同比增31%",
    "href": "http://stock.jrj.com.cn/2019/02/12173327034897.shtml",
    "datetime": "2019-02-12 17:33:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/31001027004496.shtml",
    "datetime": "2019-01-31 00:10:00",
    "code": "300294"
  },
  {
    "title": "博雅生物2018年净利最高可达4.81亿元 同比增长35%",
    "href": "http://stock.jrj.com.cn/2019/01/31000427004469.shtml",
    "datetime": "2019-01-31 00:04:55",
    "code": "300294"
  },
  {
    "title": "博雅生物：2018年净利预增25%-35%",
    "href": "http://stock.jrj.com.cn/2019/01/30162027002363.shtml",
    "datetime": "2019-01-30 16:20:00",
    "code": "300294"
  },
  {
    "title": "博雅生物2018年度净利润预增25%-35%",
    "href": "http://stock.jrj.com.cn/2019/01/30160627002308.shtml",
    "datetime": "2019-01-30 16:06:17",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物技术中心被认定为“国家企业技术中心”",
    "href": "http://stock.jrj.com.cn/2019/01/16000026913605.shtml",
    "datetime": "2019-01-16 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物技术中心被认定为“国家企业技术中心”",
    "href": "http://stock.jrj.com.cn/2019/01/16000028979490.shtml",
    "datetime": "2019-01-16 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物技术中心被认定为“国家企业技术中心”",
    "href": "http://stock.jrj.com.cn/2019/01/16000031004507.shtml",
    "datetime": "2019-01-16 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：控股子公司获得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/01/04161226853305.shtml",
    "datetime": "2019-01-04 16:12:33",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获“2017年度金牛最具投资价值奖”",
    "href": "http://stock.jrj.com.cn/2018/11/16000025356615.shtml",
    "datetime": "2018-11-16 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获“2017年度金牛最具投资价值奖”",
    "href": "http://stock.jrj.com.cn/2018/11/16000031004504.shtml",
    "datetime": "2018-11-16 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物股东高特佳集团质押60万股 占其持有公司股份的0.45%",
    "href": "http://stock.jrj.com.cn/2018/11/08075925317282.shtml",
    "datetime": "2018-11-08 07:59:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：拟斥资1亿—2亿元回购股份",
    "href": "http://stock.jrj.com.cn/hotstock/2018/11/06080025308974.shtml",
    "datetime": "2018-11-06 08:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物拟斥资1亿至2亿元回购公司股份",
    "href": "http://stock.jrj.com.cn/2018/11/05201825307555.shtml",
    "datetime": "2018-11-05 20:18:12",
    "code": "300294"
  },
  {
    "title": "博雅生物：拟1亿元至2亿元回购股份",
    "href": "http://stock.jrj.com.cn/2018/11/05194725307466.shtml",
    "datetime": "2018-11-05 19:47:00",
    "code": "300294"
  },
  {
    "title": "博雅生物3名股东合计补充质押574万股 占其所持公司股份39.65%",
    "href": "http://stock.jrj.com.cn/2018/10/24080725252108.shtml",
    "datetime": "2018-10-24 08:07:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/10182025182584.shtml",
    "datetime": "2018-10-10 18:20:00",
    "code": "300294"
  },
  {
    "title": "博雅生物前三季度净利润预增15%-45%",
    "href": "http://stock.jrj.com.cn/2018/10/10163125182007.shtml",
    "datetime": "2018-10-10 16:31:10",
    "code": "300294"
  },
  {
    "title": "博雅生物：前三季度净利润同比预增15%至45%",
    "href": "http://stock.jrj.com.cn/2018/10/10163025181976.shtml",
    "datetime": "2018-10-10 16:30:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获2017年度江西省科技进步一等奖",
    "href": "http://stock.jrj.com.cn/2018/09/07000025061523.shtml",
    "datetime": "2018-09-07 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获2017年度江西省科技进步一等奖",
    "href": "http://stock.jrj.com.cn/2018/09/07000028979493.shtml",
    "datetime": "2018-09-07 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获2017年度江西省科技进步一等奖",
    "href": "http://stock.jrj.com.cn/2018/09/07000031004492.shtml",
    "datetime": "2018-09-07 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获“第十二届上市公司价值评选”三项大奖",
    "href": "http://stock.jrj.com.cn/2018/08/15000024955260.shtml",
    "datetime": "2018-08-15 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获“第十二届上市公司价值评选”三项大奖",
    "href": "http://stock.jrj.com.cn/2018/08/15000028979494.shtml",
    "datetime": "2018-08-15 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获“第十二届上市公司价值评选”三项大奖",
    "href": "http://stock.jrj.com.cn/2018/08/15000031004493.shtml",
    "datetime": "2018-08-15 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：董事长增持27万股 持股比例升至5%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/07/02075924754596.shtml",
    "datetime": "2018-07-02 07:59:58",
    "code": "300294"
  },
  {
    "title": "博雅生物：董事长增持公司股份至5% 构成举牌",
    "href": "http://stock.jrj.com.cn/2018/06/29205224748225.shtml",
    "datetime": "2018-06-29 20:52:33",
    "code": "300294"
  },
  {
    "title": "博雅生物：董事长增持27万股 持股比例升至5%",
    "href": "http://stock.jrj.com.cn/2018/06/29192024747904.shtml",
    "datetime": "2018-06-29 19:20:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：严格遵守国家环保标准 不存在重大环境问题",
    "href": "http://stock.jrj.com.cn/2018/06/14155624681321.shtml",
    "datetime": "2018-06-14 15:56:02",
    "code": "300294"
  },
  {
    "title": "博雅生物与关联方设立投资基金",
    "href": "http://stock.jrj.com.cn/2018/06/10201824660221.shtml",
    "datetime": "2018-06-10 20:18:40",
    "code": "300294"
  },
  {
    "title": "博雅生物董事长拟增持不超过1.5亿元",
    "href": "http://stock.jrj.com.cn/2018/06/06211424647335.shtml",
    "datetime": "2018-06-06 21:14:51",
    "code": "300294"
  },
  {
    "title": "博雅生物：董事长拟斥资不超1.5亿元增持",
    "href": "http://stock.jrj.com.cn/2018/06/06201524647149.shtml",
    "datetime": "2018-06-06 20:15:00",
    "code": "300294"
  },
  {
    "title": "博雅生物人凝血因子Ⅷ拟纳入药品注册申请优先审评程序",
    "href": "http://stock.jrj.com.cn/2018/06/06143024645525.shtml",
    "datetime": "2018-06-06 14:30:27",
    "code": "300294"
  },
  {
    "title": "博雅生物：人凝血因子Ⅷ拟纳入药品注册申请优先审评程序",
    "href": "http://stock.jrj.com.cn/2018/06/06111024644744.shtml",
    "datetime": "2018-06-06 11:10:00",
    "code": "300294"
  },
  {
    "title": "博雅生物孙公司获得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2018/05/22101524572758.shtml",
    "datetime": "2018-05-22 10:15:05",
    "code": "300294"
  },
  {
    "title": "博雅生物：控股孙公司获药品GMP证书",
    "href": "http://stock.jrj.com.cn/2018/05/21184024569529.shtml",
    "datetime": "2018-05-21 18:40:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物牵手世界巨头,从原料血浆做起,国际化迈出坚实一步",
    "href": "http://stock.jrj.com.cn/2018/05/11000028979505.shtml",
    "datetime": "2018-05-11 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物牵手世界巨头,从原料血浆做起,国际化迈出坚实一步",
    "href": "http://stock.jrj.com.cn/2018/05/11000024568257.shtml",
    "datetime": "2018-05-11 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物牵手世界巨头,从原料血浆做起,国际化迈出坚实一步",
    "href": "http://stock.jrj.com.cn/2018/05/11000031004496.shtml",
    "datetime": "2018-05-11 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物与Grifols达成协议 共同设立单采血浆站",
    "href": "http://stock.jrj.com.cn/2018/05/10224624523762.shtml",
    "datetime": "2018-05-10 22:46:04",
    "code": "300294"
  },
  {
    "title": "博雅生物：与血液制品企业Grifols共同设立单采血浆站",
    "href": "http://stock.jrj.com.cn/2018/05/10155524521738.shtml",
    "datetime": "2018-05-10 15:55:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：2018年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/09221024364565.shtml",
    "datetime": "2018-04-09 22:10:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：关于非公开发行股票复牌的公告",
    "href": "http://stock.jrj.com.cn/2018/04/02204024340684.shtml",
    "datetime": "2018-04-02 20:40:00",
    "code": "300294"
  },
  {
    "title": "博雅生物、万孚生物及易成新能27日起停牌",
    "href": "http://stock.jrj.com.cn/2018/03/27124124305512.shtml",
    "datetime": "2018-03-27 12:41:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物受邀参加“红谷看金融”国际产融峰会",
    "href": "http://stock.jrj.com.cn/2018/03/27000031004494.shtml",
    "datetime": "2018-03-27 00:00:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：近期A股市场大幅波动 暂缓实施非公开发行",
    "href": "http://stock.jrj.com.cn/2018/02/07195524081429.shtml",
    "datetime": "2018-02-07 19:55:00",
    "code": "300294"
  },
  {
    "title": "博雅生物：拟对控股子公司复大医药增资5000万元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/01/18075923965325.shtml",
    "datetime": "2018-01-18 07:59:58",
    "code": "300294"
  },
  {
    "title": "博雅生物增资子公司复大医药",
    "href": "http://stock.jrj.com.cn/2018/01/17210023963435.shtml",
    "datetime": "2018-01-17 21:00:15",
    "code": "300294"
  },
  {
    "title": "博雅生物：2017年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/01/11223023933378.shtml",
    "datetime": "2018-01-11 22:30:00",
    "code": "300294"
  },
  {
    "title": "博雅生物2017年度业绩预增15%-45%",
    "href": "http://stock.jrj.com.cn/2018/01/11214123933232.shtml",
    "datetime": "2018-01-11 21:41:20",
    "code": "300294"
  },
  {
    "title": "[博雅生物]抚州市委书记肖毅一行调研 博雅生物凝血因子产品工程研究中心",
    "href": "http://stock.jrj.com.cn/2018/01/11000031004495.shtml",
    "datetime": "2018-01-11 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]抚州市委书记肖毅一行调研 博雅生物凝血因子产品工程研究中心",
    "href": "http://stock.jrj.com.cn/2018/01/11000028979502.shtml",
    "datetime": "2018-01-11 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获第二届江西省井冈质量奖提名奖",
    "href": "http://stock.jrj.com.cn/2018/01/03000023890177.shtml",
    "datetime": "2018-01-03 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获“2017年江西省两化融合先进单位”称号",
    "href": "http://stock.jrj.com.cn/2018/01/03000023890176.shtml",
    "datetime": "2018-01-03 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获第二届江西省井冈质量奖提名奖",
    "href": "http://stock.jrj.com.cn/2018/01/03000028979485.shtml",
    "datetime": "2018-01-03 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]博雅生物荣获“2017年江西省两化融合先进单位”称号",
    "href": "http://stock.jrj.com.cn/2018/01/03000028979487.shtml",
    "datetime": "2018-01-03 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]2017年度江西省药物分析学术交流会顺利召开",
    "href": "http://stock.jrj.com.cn/2018/01/03000028979486.shtml",
    "datetime": "2018-01-03 00:00:00",
    "code": "300294"
  },
  {
    "title": "[博雅生物]2017年度江西省药物分析学术交流会顺利召开",
    "href": "http://stock.jrj.com.cn/2018/01/03000023890175.shtml",
    "datetime": "2018-01-03 00:00:00",
    "code": "300294"
  },
  {
    "title": "11月29日重要公告：博雅生物于非公开发行A股股票获证监会发行审核委员会通过",
    "href": "http://stock.jrj.com.cn/2017/11/28184823709059.shtml",
    "datetime": "2017-11-28 18:48:00",
    "code": "300294"
  },
  {
    "title": "博雅生物人凝血因子Ⅷ生产批件申请获受理",
    "href": "http://stock.jrj.com.cn/2017/11/27212023703271.shtml",
    "datetime": "2017-11-27 21:20:09",
    "code": "300294"
  }
]